Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle sit down and talk about topics in the news including what psychedelic companies owe to the community (both indigenous people and the underground psychedelic world), psilocybin-like drug alternatives for treating depression and the many reasons newer companies are trying to remove the psychedelic part of the medicine, and Dennis McKenna’s recent appointing to New Wave Holdings’ psychedelic research advisory board and what that says about the current climate of corporations moving into this space. They discuss the dangers of “sponsored content”-like corporate messages, the malleability of laws and power of lobbyists and interest groups, and how manipulation is faster and quieter than ever before, while many big decisions are being made by people crippled from decades of unseen cultural baggage. And why are companies trying to remove the psychedelic side of medicine? Is it solely for profit, or could it be because there are so many in need that streamlining the